
    
      Part I: SAD of OSCN- and bLF in healthy male volunteers (cohorts 1 to 3) - Part II: SAD and
      MAD of ALX-009 in healthy male volunteers (cohorts 4 and 5) - Part III: MAD of OSCN- and bLF
      in patients suffering from cystic fibrosis (cohort III-1) and in healthy volunteers (cohorts
      III-2 and III-3) - Part IV: MAD of ALX-009 in healthy volunteers (Part IVa - Cohorts IV-1a to
      IV-3a) and in patients (Part IVb - Cohorts IV-1b to IV-3b)
    
  